Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy.

Walsh CS.

Gynecol Oncol. 2015 Feb 25. pii: S0090-8258(15)00657-5. doi: 10.1016/j.ygyno.2015.02.017. [Epub ahead of print] Review.

2.

The growing season, but not the farming system, is a food safety risk determinant for leafy greens in the mid-atlantic region of the United States.

Marine SC, Pagadala S, Wang F, Pahl DM, Melendez MV, Kline WL, Oni RA, Walsh CS, Everts KL, Buchanan RL, Micallef SA.

Appl Environ Microbiol. 2015 Apr 1;81(7):2395-407. doi: 10.1128/AEM.00051-15. Epub 2015 Jan 23.

PMID:
25616798
3.

Assessment of region, farming system, irrigation source and sampling time as food safety risk factors for tomatoes.

Pagadala S, Marine SC, Micallef SA, Wang F, Pahl DM, Melendez MV, Kline WL, Oni RA, Walsh CS, Everts KL, Buchanan RL.

Int J Food Microbiol. 2015 Mar 2;196:98-108. doi: 10.1016/j.ijfoodmicro.2014.12.005. Epub 2014 Dec 13.

PMID:
25540859
4.

Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.

Block MS, Charbonneau B, Vierkant RA, Fogarty Z, Bamlet WR, Pharoah PD; Georgia Chenevix-Trench; for AOCS; /ACS Group, Rossing MA, Cramer D, Pearce CL, Schildkraut J, Menon U, Kjaer SK, Levine DA, Gronwald J, Culver HA, Whittemore AS, Karlan BY, Lambrechts D, Wentzensen N, Kupryjanczyk J, Chang-Claude J, Bandera EV, Hogdall E, Heitz F, Kaye SB, Fasching PA, Campbell I, Goodman MT, Pejovic T, Bean YT, Hays LE, Lurie G, Eccles D, Hein A, Beckmann MW, Ekici AB, Paul J, Brown R, Flanagan JM, Harter P, du Bois A, Schwaab I, Hogdall CK, Lundvall L, Olson SH, Orlow I, Paddock LE, Rudolph A, Eilber U, Dansonka-Mieszkowska A, Rzepecka IK, Ziolkowska-Seta I, Brinton LA, Yang H, Garcia-Closas M, Despierre E, Lambrechts S, Vergote I, Walsh CS, Lester J, Sieh W, McGuire V, Rothstein JH, Ziogas A, Lubiński J, Cybulski C, Menkiszak J, Jensen A, Gayther SA, Ramus SJ, Gentry-Maharaj A, Berchuck A, Wu AH, Pike MC, Van Den Berg D, Terry KL, Vitonis AF, Ramirez SM, Rider DN, Knutson KL, Sellers TA, Phelan CM, Doherty JA, Johnatty SE, deFazio A, Song H, Tyrer J, Kalli KR, Fridley BL, Cunningham JM, Goode EL.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1421-7. doi: 10.1158/1055-9965.EPI-13-0962. Epub 2014 Apr 16.

5.

Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival.

Cohen JG, Tran AQ, Rimel BJ, Cass I, Walsh CS, Karlan BY, Li AJ.

Gynecol Oncol. 2014 Mar;132(3):556-9. doi: 10.1016/j.ygyno.2014.01.003. Epub 2014 Jan 11.

PMID:
24423879
6.

Post treatment surveillance of type II endometrial cancer patients.

Zakhour M, Li AJ, Walsh CS, Cass I, Karlan BY, Rimel BJ.

Gynecol Oncol. 2013 Dec;131(3):609-12. doi: 10.1016/j.ygyno.2013.09.008. Epub 2013 Sep 17.

PMID:
24051222
7.

Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival.

Diaz ES, Walts AE, Karlan BY, Walsh CS.

Gynecol Oncol. 2013 Dec;131(3):541-5. doi: 10.1016/j.ygyno.2013.09.005. Epub 2013 Sep 14.

PMID:
24041880
8.

Comparing source of agricultural contact water and the presence of fecal indicator organisms on the surface of 'juliet' grape tomatoes.

Pahl DM, Telias A, Newell M, Ottesen AR, Walsh CS.

J Food Prot. 2013 Jun;76(6):967-74. doi: 10.4315/0362-028X.JFP-12-204.

PMID:
23726191
9.

Summary of the 44th Annual Meeting on Women's Cancers.

Alvarez Secord A, Walsh CS.

Gynecol Oncol. 2013 May;129(2):273-6. doi: 10.1016/j.ygyno.2013.03.028. No abstract available.

PMID:
23582582
10.

Predictors of invasive adenocarcinoma after conization for cervical adenocarcinoma in situ.

ElMasri WM, Walts AE, Chiang A, Walsh CS.

Gynecol Oncol. 2012 Jun;125(3):589-93. doi: 10.1016/j.ygyno.2012.03.005. Epub 2012 Mar 9.

PMID:
22410327
11.

Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, Andrulis IL; OCGN, Ozcelik H, Mulligan AM, Thomassen M, Gerdes AM, Jensen UB, Skytte AB, Kruse TA, Caligo MA, von Wachenfeldt A, Barbany-Bustinza G, Loman N, Soller M, Ehrencrona H, Karlsson P; SWE-BRCA, Nathanson KL, Rebbeck TR, Domchek SM, Jakubowska A, Lubinski J, Jaworska K, Durda K, Zlowocka E, Huzarski T, Byrski T, Gronwald J, Cybulski C, Górski B, Osorio A, Durán M, Tejada MI, Benitez J, Hamann U, Hogervorst FB; HEBON, van Os TA, van Leeuwen FE, Meijers-Heijboer HE, Wijnen J, Blok MJ, Kets M, Hooning MJ, Oldenburg RA, Ausems MG, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Jacobs C, Eeles RA, Adlard J, Davidson R, Eccles DM, Cole T, Cook J, Paterson J, Brewer C, Douglas F, Hodgson SV, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Side LE; EMBRACE, Bove B, Godwin AK, Stoppa-Lyonnet D; GEMO Study Collaborators, Fassy-Colcombet M, Castera L, Cornelis F, Mazoyer S, Léoné M, Boutry-Kryza N, Bressac-de Paillerets B, Caron O, Pujol P, Coupier I, Delnatte C, Akloul L, Lynch HT, Snyder CL, Buys SS, Daly MB, Terry M, Chung WK, John EM, Miron A, Southey MC, Hopper JL, Goldgar DE, Singer CF, Rappaport C, Tea MK, Fink-Retter A, Hansen TV, Nielsen FC, Arason A, Vijai J, Shah S, Sarrel K, Robson ME, Piedmonte M, Phillips K, Basil J, Rubinstein WS, Boggess J, Wakeley K, Ewart-Toland A, Montagna M, Agata S, Imyanitov EN, Isaacs C, Janavicius R, Lazaro C, Blanco I, Feliubadalo L, Brunet J, Gayther SA, Pharoah PP, Odunsi KO, Karlan BY, Walsh CS, Olah E, Teo SH, Ganz PA, Beattie MS, van Rensburg EJ, Dorfling CM, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Heinritz W, Caldes T, de la Hoya M, Muranen TA, Nevanlinna H, Tischkowitz MD, Spurdle AB, Neuhausen SL, Ding YC, Lindor NM, Fredericksen Z, Pankratz VS, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Bernard L, Viel A, Giannini G, Varesco L, Radice P, Greene MH, Mai PL, Easton DF, Chenevix-Trench G; kConFab investigators, Offit K, Simard J; Consortium of Investigators of Modifiers of BRCA1/2.

Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):645-57. doi: 10.1158/1055-9965.EPI-11-0888. Epub 2012 Feb 20.

12.

Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment.

Taylor-Harding B, Agadjanian H, Nassanian H, Kwon S, Guo X, Miller C, Karlan BY, Orsulic S, Walsh CS.

Br J Cancer. 2012 Jan 17;106(2):333-43. doi: 10.1038/bjc.2011.546. Epub 2011 Dec 13.

13.

Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy.

Penner KR, Dorigo O, Aoyama C, Ostrzega N, Balzer BL, Rao J, Walsh CS, Cass I, Holschneider CH.

Gynecol Oncol. 2012 Mar;124(3):542-8. doi: 10.1016/j.ygyno.2011.11.004. Epub 2011 Nov 10.

PMID:
22079678
14.

Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.

Fleming ND, Agadjanian H, Nassanian H, Miller CW, Orsulic S, Karlan BY, Walsh CS.

Cancer. 2012 Feb 1;118(3):689-97. doi: 10.1002/cncr.26329. Epub 2011 Jul 12. Erratum in: Cancer. 2012 Nov 1;118(21):5450.

15.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Barile M, Pensotti V, Pasini B, Dolcetti R, Giannini G, Putignano AL, Varesco L, Radice P, Mai PL, Greene MH, Andrulis IL, Glendon G, Ozcelik H, Thomassen M, Gerdes AM, Kruse TA, Birk Jensen U, Crüger DG, Caligo MA, Laitman Y, Milgrom R, Kaufman B, Paluch-Shimon S, Friedman E, Loman N, Harbst K, Lindblom A, Arver B, Ehrencrona H, Melin B; SWE-BRCA, Nathanson KL, Domchek SM, Rebbeck T, Jakubowska A, Lubinski J, Gronwald J, Huzarski T, Byrski T, Cybulski C, Gorski B, Osorio A, Ramón y Cajal T, Fostira F, Andrés R, Benitez J, Hamann U, Hogervorst FB, Rookus MA, Hooning MJ, Nelen MR, van der Luijt RB, van Os TA, van Asperen CJ, Devilee P, Meijers-Heijboer HE, Gómez Garcia EB; HEBON, Peock S, Cook M, Frost D, Platte R, Leyland J, Evans DG, Lalloo F, Eeles R, Izatt L, Adlard J, Davidson R, Eccles D, Ong KR, Cook J, Douglas F, Paterson J, Kennedy MJ, Miedzybrodzka Z; EMBRACE, Godwin A, Stoppa-Lyonnet D, Buecher B, Belotti M, Tirapo C, Mazoyer S, Barjhoux L, Lasset C, Leroux D, Faivre L, Bronner M, Prieur F, Nogues C, Rouleau E, Pujol P, Coupier I, Frénay M; CEMO Study Collaborators, Hopper JL, Daly MB, Terry MB, John EM, Buys SS, Yassin Y, Miron A, Goldgar D; Breast Cancer Family Registry, Singer CF, Tea MK, Pfeiler G, Dressler AC, Hansen Tv, Jønson L, Ejlertsen B, Barkardottir RB, Kirchhoff T, Offit K, Piedmonte M, Rodriguez G, Small L, Boggess J, Blank S, Basil J, Azodi M, Toland AE, Montagna M, Tognazzo S, Agata S, Imyanitov E, Janavicius R, Lazaro C, Blanco I, Pharoah PD, Sucheston L, Karlan BY, Walsh CS, Olah E, Bozsik A, Teo SH, Seldon JL, Beattie MS, van Rensburg EJ, Sluiter MD, Diez O, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ruehl I, Varon-Mateeva R, Kast K, Deissler H, Niederacher D, Arnold N, Gadzicki D, Schönbuchner I, Caldes T, de la Hoya M, Nevanlinna H, Aittomäki K, Dumont M, Chiquette J, Tischkowitz M, Chen X, Beesley J, Spurdle AB; kConFab investigators, Neuhausen SL, Chun Ding Y, Fredericksen Z, Wang X, Pankratz VS, Couch F, Simard J, Easton DF, Chenevix-Trench G; CIMBA.

Hum Mol Genet. 2011 Aug 15;20(16):3304-21. doi: 10.1093/hmg/ddr226. Epub 2011 May 18.

16.

Bacterial community diversity and variation in spray water sources and the tomato fruit surface.

Telias A, White JR, Pahl DM, Ottesen AR, Walsh CS.

BMC Microbiol. 2011 Apr 21;11:81. doi: 10.1186/1471-2180-11-81.

17.

CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer.

Fleming ND, Cass I, Walsh CS, Karlan BY, Li AJ.

Gynecol Oncol. 2011 May 1;121(2):249-52. doi: 10.1016/j.ygyno.2011.01.014. Epub 2011 Feb 5.

PMID:
21300398
18.

Is older age a poor prognostic factor in stage I and II endometrioid endometrial adenocarcinoma?

Fleming ND, Lentz SE, Cass I, Li AJ, Karlan BY, Walsh CS.

Gynecol Oncol. 2011 Feb;120(2):189-92. doi: 10.1016/j.ygyno.2010.10.038. Epub 2010 Nov 26.

PMID:
21112078
19.

Molecular signatures of ovarian cancer: from detection to prognosis.

Walsh CS, Karlan BY.

Mol Diagn Ther. 2010 Feb 1;14(1):13-22. doi: 10.2165/11530880-000000000-00000. Review.

PMID:
20121286
20.

Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening.

Walsh CS, Blum A, Walts A, Alsabeh R, Tran H, Koeffler HP, Karlan BY.

Gynecol Oncol. 2010 Mar;116(3):516-21. doi: 10.1016/j.ygyno.2009.11.021. Epub 2010 Jan 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk